Oct 07,2021

DarioHealth Announces Agreement with Global Employer for Metabolic and Musculoskeletal Health Solutions

DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, announced today an agreement with a global company based in the United States ("Company") to provide its integrated digital health management solution for diabetes, hypertension, and musculoskeletal (MSK) health. The contract is expected to launch in the first quarter of 2022. The Company selected Dario to provide a highly personalized approach to chronic condition management to help improve employee health and reduce the cost of care.

PRODUCT

#coaching

View Analyst & Ambassador Comments
Go to original news
Oct 15,2021

JAMA Study of over 28,000 Participants Finds 84% of Hello Heart Users Reduced Blood Pressure Over Three Years

Hello Heart, the only digital therapeutics company to focus exclusively on heart disease, today announced that its digital health application for blood pressure management can achieve and maintain lower blood pressure over time, even for those most at risk for heart disease. The results, published in JAMA Network Open, a peer-reviewed journal of the American Medical Association, showed that over 84 percent of participants with stage II hypertension achieved a reduction in their systolic blood pressure, which was maintained over three years.

CLINICAL STUDY

#connected device

#mobile app

View Analyst & Ambassador Comments
Go to original news
Oct 25,2021

DarioHealth Announces Contract with a U.S. National Employer to Provide Its Full Multi-Condition Suite Digital Therapeutic Solutions

DarioHealth announced today that it has entered into a contract with a U.S. national employer (the "Employer") for the Company's full multi-condition suite of chronic condition management solutions, including diabetes, pre-diabetes, hypertension, musculoskeletal, behavioral health, and digital employee assistance programs. Enrollment of the Company's multi-condition suite of chronic condition management solutions is expected to begin in the first quarter of 2022, consistent with the Employer's benefit year.

PRODUCT

#coaching

#software

View Analyst & Ambassador Comments
Go to original news
Nov 01,2021

DarioHealth Gathers Momentum in the Provider Market with Two New Contracts for Remote Patient Monitoring Services

DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, announced today that it has entered into contracts with two prominent regional providers in Hawaii and Georgia for its Remote Patient Monitoring (RPM) services. Both partnerships will provide RPM services for patients living with diabetes and hypertension, two of the most common – and commonly co-occurring - chronic conditions.

PRODUCT

#rpm

#software

View Analyst & Ambassador Comments
Go to original news
Nov 03,2021

DarioHealth Partners with National Group Benefits Platform

DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, announced today a new strategic partnership with a leading national benefits administrative platform ("Benefits Platform"), to provide its full suite of integrated digital therapeutic and health solutions to a wide range of employers, beginning in January of 2022. The Benefits Platform will offer Dario's full suite of integrated chronic condition solutions for diabetes, pre-diabetes, hypertension, weight management, musculoskeletal and behavioral health to individuals and organizations through its platform.

PRODUCT
View Analyst & Ambassador Comments
Go to original news
Dec 21,2021

DarioHealth Selected as Exclusive Digital Therapeutics Provider to a Leading Benefits Brokerage

DarioHealth Corp., a leader in the global digital therapeutics (DTx) market, announced a new strategic partnership with a leading employer benefits brokerage to sell its digital therapeutic solutions for diabetes, hypertension and musculoskeletal health as part of a new premier employee health benefits product for small businesses. The product will be made available to the Partner’s more than 2,300 clients beginning in early 2022.

PRODUCT
View Analyst & Ambassador Comments
Go to original news
Apr 08,2021

Omada Health Unveils the Omada Insights Lab, a Cross-Functional, Data-Driven Initiative Aiming to Transform Healthcare Delivery and Outcomes

Driven by its expansion to an integrated platform across five conditions, today, virtual care provider Omada Health unveils the Omada Insights Lab, its internal initiative that leverages Omada’s deep multi-disciplinary expertise to transform care delivery and apply learnings into innovative, cost-effective interventions. The Omada Insights Lab leverages its internal expertise across five cross-functional teams: data science, behavior science, clinical design, product design, and care delivery to optimize its healthcare programs. Having recently added Musculoskeletal to Omada’s integrated platform, Omada has unique visibility across conditions on how to refine, optimize, and improve the individualized care Omada provides to help its members.

PRODUCT

#virtual care

View Analyst & Ambassador Comments
Go to original news
May 25,2021

Omada Health Becomes First Fully-Virtual Healthcare Provider to Earn NCQA Population Health Program Accreditation

Following its groundbreaking launch of Physician-Guided Care for diabetes and hypertension, Omada Health’s Type 2 Diabetes and Type 2 Diabetes+Hypertension programs have been awarded the National Committee for Quality Assurance’s (NCQA) Population Health Program (PHP) Accreditation. As the first fully-virtual healthcare provider to earn this accreditation, Omada was recognized for its clinical excellence and best-in-class holistic member care. This certification is a significant milestone in Omada’s ongoing commitment to transforming chronic care treatment through behavior science.

PRODUCT

#virtual care

View Analyst & Ambassador Comments
Go to original news
Dec 15,2021

Omada Health Secures Preferred Status on Evernorth’s Digital Health Formulary for Diabetes, Hypertension and Prediabetes Solutions

Omada Health announced today that it has earned preferred status on the Evernorth Digital Health Formulary for its cardiometabolic digital chronic care programs: Diabetes, Hypertension and Prevention. As a preferred solution, participating employers and health plans have the ability to simplify their integration experience with Omada Health through Express Scripts, a pharmacy benefit manager that supports over 100 million members. Evernorth added Omada Health to the Digital Health Formulary in December of 2019.

PRODUCT

#virtual care

View Analyst & Ambassador Comments
Go to original news
Sep 30,2021

Onduo and Fitbit Collaborate to Provide Onduo Members with Fitbit Devices and Services to Help Manage Their Holistic Health

Today, Onduo, part of Verily, Alphabet’s life sciences subsidiary, announced that it will offer Fitbit devices and Fitbit Premium as part of the company’s approach to whole person health. Available to employees who enroll in an Onduo program supported through their employer, participants will have the opportunity to request a Fitbit device seamlessly through the Onduo experience.

COLLABORATION PARTNERSHIP

#product & service

#coaching

#dtx

View Analyst & Ambassador Comments
Go to original news
Subscribe to HYPERTENSION